...
首页> 外文期刊>Phytotherapy research: PTR >Comparison of Enteroprotective Efficacy of Triphala Formulations (Indian Herbal Drug) on Methotrexate-Induced Small Intestinal Damage in Rats
【24h】

Comparison of Enteroprotective Efficacy of Triphala Formulations (Indian Herbal Drug) on Methotrexate-Induced Small Intestinal Damage in Rats

机译:Triphala制剂(印度草药)对甲氨蝶呤致大鼠小肠损伤的肠保护功效的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Triphala is categorized as a rejuvenator and antioxidant-rich Ayurvedic herbal formulation and has traditionally been used in various gastric problems including intestinal inflammation. The aim of the present study was to examine the comparative enteroprotective effect of Triphala formulations against methotrexate-induced intestinal damage in rats. Triphala formulations were prepared by mixing equal (1:1:1) and unequal (1:2:4) proportions of Terminalia chebula Retz., Terminalia belerica (Gaertn.) Roxb. and Emblica officinalis Gaertn. Intestinal damage was induced by administering methotrexate (MTX) in a dose of 12 mg/kg, orally for 4 days to albino rats. The intestinal damage response was assessed by gross and microscopical injury, measuring the intestinal permeability to phenol red and tissue biochemical parameters. Triphala equal and unequal formulations at the dose of 540 mg/kg significantly restored the depleted protein level in brush border membrane of intestine, phospholipid and glutathione content and decreased the myeloperoxidase and xanthine oxidase level in intestinal mucosa of methotrexate-treated rats. In addition, Triphala unequal formulation showed significant decrease in permeation clearance of phenol red with significant attenuation in the histopathological changes, level of disaccharidase in brush border membrane vesicles and lipid peroxidation content of intestinal mucosa. Based on the data generated, it is suggested that Triphala unequal formulation provides significantly more protection than Triphala equal formulation against methotrexate-induced damage in rat intestine.
机译:Triphala被归类为嫩肤剂和富含抗氧化剂的阿育吠陀草药制剂,传统上已用于各种胃部疾病,包括肠道炎症。本研究的目的是研究Triphala制剂对甲氨蝶呤诱导的大鼠肠道损伤的比较肠保护作用。通过混合相等比例(1:1:1)和不相等比例(1:2:4)的Terminalia chebula Retz。,Terminalia belerica(Gaertn。)Roxb来配制Triphala制剂。和Emblica officinalis Gaertn。通过对白化病大鼠口服甲氨蝶呤(MTX)剂量为12 mg / kg持续4天,可引起肠损伤。通过肉眼和微观损伤评估肠道损伤反应,测量肠道对酚红的渗透性和组织生化参数。相同剂量和不同剂量的Triphala配方(540 mg / kg)可显着恢复肠道刷状边界膜上的蛋白质消耗水平,磷脂和谷胱甘肽含量,并降低甲氨蝶呤治疗大鼠肠黏膜中的髓过氧化物酶和黄嘌呤氧化酶水平。此外,Triphala不等制剂显示酚红的渗透清除率显着降低,同时组织病理学变化,刷状缘膜囊泡中的二糖苷酶水平和肠粘膜脂质过氧化含量显着降低。根据产生的数据,建议Triphala不等剂量制剂对甲氨蝶呤引起的大鼠肠道损伤提供比Triphala等剂量制剂明显更多的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号